Single Stage Nipple-Sparing Mastectomy and Reduction Mastopexy in the Ptotic Breast

Table 1

Patient characteristics and procedural specifics.

Pt	Age	Sex	Smoker	PMH	Indication	Ptosis grade	Technique	Expander size	Breast volume excised (R/L)
1	55	F	No	Hypertension	Biopsy with atypical cells in the setting of bilateral silicone injections	III; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	350 cc	665 gr/740 gr
2	30	F	No	Asthma, depression	BRCA mutation	III; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	800 cc	1240 gr/1316 gr
3	54	F	No	Gastric cancer, thyroid disease, peripheral neuropathy	BRCA mutation	III; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	400 cc	429 gr/449 gr
4	58	F	No	Thyroid disease	BRCA mutation	III; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	800 cc	1006 gr/776 gr
5	52	F	Yes	None	Unilateral, multifocal DCIS	III; (B/L)	Bilateral NSM with reduction mammaplasty and DIEP flap reconstruction	N/A	NR
6	58	F	No	Hypertension, diabetes mellitus	Unilateral invasive breast cancer, BRCA	III/II; (R/L)	Bilateral NSM with reduction mammaplasty and DIEP flap reconstruction	N/A	546 gr/436 gr
7	32	F	Yes	None	Unilateral invasive breast cancer	II; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	500 cc	NR
8	55	F	Yes	Ovarian cancer, thyroid disease	BRCA	II; (B/L)	Bilateral NSM with reduction mammaplasty and expander insertion	500 cc	NR

PMH: past medical history; R: right; L: left; B/L: bilateral; NSM: nipple-sparing mastectomy; BRCA: breast cancer susceptibility gene; DCIS: ductal carcinoma in situ; N/A: not applicable; DIEP: deep inferior epigastric perforator; NR: not reported.